Just Skinny Enough: District Court Dismisses Inducement Claims Against Generic Skinny Label | Rothwell, Figg, Ernst & Manbeck, P.C.

On January 4, 2022, the District Court for the District of Delaware granted Hikma Pharmaceuticals USA Inc.’s (“Hikma”) motion to dismiss Amarin Pharma Inc.’s (“Amarin”) infringement...

Related Keywords

Delaware ,United States ,Takeda Pharms ,States Teva ,Richardg Andrews ,Teva Pharms ,Hikma Pharms ,Alkem Labs Ltd ,Health Net ,District Court ,Amicus Brief Of Mylan Pharmaceuticals Inc ,Hikma Pharmaceuticals United States Inc ,Teva Pharmaceuticals ,United States Inc ,Amarin Pharma Inc ,See Glaxosmithkline ,Amicus Brief Of Apotex Inc ,Sa Inc ,Hikma Pharmaceuticals United States ,Amarin Pharma ,Federal Circuit ,Federal Circuit Law ,Hatch Waxman Act ,Judge Prost ,Labs Ltd ,Judge Richard ,Judge Andrews ,Judge Andrew ,Magistrate Judge ,Amicus Brief ,Mylan Pharmaceuticals Inc ,